|
業務類別
|
Medical Devices |
|
業務概覽
|
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific. |
| 公司地址
| 50 Milk Street, 10th Floor, Boston, MA, USA, 02109 |
| 電話號碼
| +1 650 266-6000 |
| 傳真號碼
| +1 650 871-7152 |
| 公司網頁
| https://www.standardbio.com |
| 員工數量
| 389 |
| Mr. Sean Mackay |
Chief Business Officer |
美元 471.89K |
27/04/2026 |
| Dr. Michael Egholm, PhD |
President, Chief Executive Officer and Director |
美元 680.26K |
27/04/2026 |
| Mr. Hanjoon Alex Kim |
Chief Financial Officer and Principal Accounting Officer |
美元 496.72K |
27/04/2026 |
|
|
| Dr. Michael Egholm, PhD |
President, Chief Executive Officer and Director |
27/04/2026 |
| Ms. Kathy L. Hibbs, J.D. |
Independent Director |
27/04/2026 |
| Mr. Troy M. Cox, M.B.A. |
Independent Director |
27/04/2026 |
| Mr. Eli D. Casdin, M.B.A. |
Independent Director |
27/04/2026 |
| Dr. Franklin R. Witney, PhD |
Independent Director |
27/04/2026 |
| Mr. Fenel M. Eloi |
Independent Director |
27/04/2026 |
| Mr. Thomas Carey |
Chairman of the Board |
27/04/2026 |
|
|
|
|
